Drug Company Execs Agree to Testify on Prescription Prices
The chief executive officers at Johnson & Johnson and Merck reportedly dodged a possible subpoena - and have agreed to testify at a Senate hearing in February that will focus on prescription drug prices.
The chief executive officers at Johnson & Johnson and Merck reportedly dodged a possible subpoena - and have agreed to testify at a Senate hearing in February that will focus on prescription drug prices.
What's Your Reaction?
